Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Virological failure among adolescents on ART, Harare City, 2017- a case-control study

Authors: Zvanaka Sithole, Elizabeth Mbizvo, Prosper Chonzi, More Mungati, Tsitsi Patience Juru, Gerald Shambira, Notion Tafara Gombe, Mufuta Tshimanga

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Zimbabwe is on track towards achieving viral suppression among adults (87%). However, adolescents have only achieved 44% by 2016. In Harare city, 57% of adolescents had attained viral suppression after 12 months on ART compared to 88% among adults. We determined factors associated with virological failure among adolescents (age 10–19 years) on antiretroviral therapy (ART) in Harare city.

Methods

We conducted a one to one unmatched case control study among 102 randomly recruited case: control pairs at the two main infectious disease hospitals in Harare. A case was any adolescent who presented with VL > 1000c/ml after at least 12 months on ART. A control was any adolescent who presented with VL < 1000c/ml after at least 12 months on ART. Interviewer administered questionnaires were used to collect data. Epi Info 7 was used to generate frequencies, means, proportions, ORs and p-values at 95% CI.

Results

We interviewed 102 case-control pairs. Poor adherence to ART [aOR = 8.15, 95% CI (2.80–11.70)], taking alcohol [aOR = 8.46, 95% CI (3.22–22.22)] and non- disclosure of HIV status [aOR = 4.56, 95% CI (2.20–9.46)] were independent risk factors for virological failure. Always using a condom [aOR = 0.04, 95% CI (0.01–0.35)], being on second line treatment [aOR = 0.04, 95% CI (0.23–0.81)] and belonging to a support group [aOR = 0.41, 95% CI (0.21–0.80)] were protective.

Conclusion

Poor adherence, alcohol consumption and non-disclosure increased the odds of virological failure. Based on these findings support should focus on behavior change and strengthening of peer to peer projects to help address issues related to disclosure and adherence. Further operational research should aim to define other components of effective adherence support for adolescents with virological failure.
Literature
1.
go back to reference WHO Consolidated guidelines on The use of Antiretroviral Drugs for Treating and Preventing HIV Infection, 2013. WHO Consolidated guidelines on The use of Antiretroviral Drugs for Treating and Preventing HIV Infection, 2013.
2.
go back to reference Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. The World Health Organization’s global strategy for prevention and assessment of HIV drug resistance. Antivir Ther. 2008;13:1–13.PubMed Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. The World Health Organization’s global strategy for prevention and assessment of HIV drug resistance. Antivir Ther. 2008;13:1–13.PubMed
3.
go back to reference Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, et al. International AIDS society-USA, et al. antiretroviral treatment of adult HIV infection: 2010. Recommendations of the international AIDS society-USA panel. JAMA. 2010;304:321–33.CrossRef Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, et al. International AIDS society-USA, et al. antiretroviral treatment of adult HIV infection: 2010. Recommendations of the international AIDS society-USA panel. JAMA. 2010;304:321–33.CrossRef
4.
go back to reference World Health Organization. Health for the World’s adolescents: a second chance in the second decade. World Health Organization: Geneva, Switzerland, 2014. World Health Organization. Health for the World’s adolescents: a second chance in the second decade. World Health Organization: Geneva, Switzerland, 2014.
5.
go back to reference World Health Organization. World Health Organization global strategy for the surveillance and monitoring of HIV drug resistance. Geneva, Switzerland: WHO; 2012. World Health Organization. World Health Organization global strategy for the surveillance and monitoring of HIV drug resistance. Geneva, Switzerland: WHO; 2012.
6.
go back to reference Zimbabwe Ministry of health and Child Care. Guidelines for Antiretroviral Therapy for the Prevention and Treatment of HIV in Zimbabwe, 2013. Zimbabwe Ministry of health and Child Care. Guidelines for Antiretroviral Therapy for the Prevention and Treatment of HIV in Zimbabwe, 2013.
7.
go back to reference Matare T, Shambira G. Factors associated with HIV first line treatment failure in Zvishavane District, Midlands Province, 2014. Matare T, Shambira G. Factors associated with HIV first line treatment failure in Zvishavane District, Midlands Province, 2014.
8.
go back to reference Chimbetete C, Tshimanga M, Wellington D. Factors associated with first line ART treatment among patients at Newlands clinic, Harare, 2011. Chimbetete C, Tshimanga M, Wellington D. Factors associated with first line ART treatment among patients at Newlands clinic, Harare, 2011.
9.
go back to reference Department of health and Health services, Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington: Department of Health and Human Services; 2012. Department of health and Health services, Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington: Department of Health and Human Services; 2012.
10.
go back to reference Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G, et al (2014) Impact and programmatic implications of routine viral load monitoring in Swaziland. JAIDS 2014;67(1):45-51.CrossRef Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G, et al (2014) Impact and programmatic implications of routine viral load monitoring in Swaziland. JAIDS 2014;67(1):45-51.CrossRef
11.
go back to reference UNAIDS. Ambitious treatment targets: writing the final chapter of the AIDS epidemic. In: Geneva; 2015. UNAIDS. Ambitious treatment targets: writing the final chapter of the AIDS epidemic. In: Geneva; 2015.
12.
go back to reference Zimbabwe Ministry of health and Child Care, National HIV/AIDS And Tuberculosis Control Programmes; National Guidelines for TB/HIV Co- Management, 2013. Zimbabwe Ministry of health and Child Care, National HIV/AIDS And Tuberculosis Control Programmes; National Guidelines for TB/HIV Co- Management, 2013.
13.
go back to reference Zimbabwe Ministry of Health and Child Care, Zimbabwe Population Based HIV Impact Assessment. Fact sheet, 2016. Zimbabwe Ministry of Health and Child Care, Zimbabwe Population Based HIV Impact Assessment. Fact sheet, 2016.
14.
go back to reference World Health Organization. Adolescent HIV Testing, Counselling and Care: Implementation guidance for health providers and planners. World Health Organization: Geneva, Switzerland, 2014. World Health Organization. Adolescent HIV Testing, Counselling and Care: Implementation guidance for health providers and planners. World Health Organization: Geneva, Switzerland, 2014.
15.
go back to reference Kip E, Ehlers VJ, Van Der Wal DM. Patients adherence to anti-retroviral therapy in Botswana. J Nurs Scholarsh. 2009;41(2):149–57.CrossRef Kip E, Ehlers VJ, Van Der Wal DM. Patients adherence to anti-retroviral therapy in Botswana. J Nurs Scholarsh. 2009;41(2):149–57.CrossRef
16.
go back to reference Evans D, Menezes C, Mahomed K, et al. Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa. AIDS Res Hum Retrovir. 2013;29(6):892–900.CrossRef Evans D, Menezes C, Mahomed K, et al. Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa. AIDS Res Hum Retrovir. 2013;29(6):892–900.CrossRef
17.
go back to reference Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006;43(4):411–7.CrossRef Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006;43(4):411–7.CrossRef
18.
go back to reference Nachega JB, Hislop M, Nguyen H, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr. 2009;51(1):65–71.CrossRef Nachega JB, Hislop M, Nguyen H, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr. 2009;51(1):65–71.CrossRef
19.
go back to reference Zanoni BC, Mayer KH. The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities. AIDS Patient Care STDs. 2014;28:128–35.CrossRef Zanoni BC, Mayer KH. The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities. AIDS Patient Care STDs. 2014;28:128–35.CrossRef
20.
go back to reference Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS care panel. Ann Intern Med. 2012;156:817–33.CrossRef Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS care panel. Ann Intern Med. 2012;156:817–33.CrossRef
21.
go back to reference Aldrovandi G, Viani RM, Peralta L, Kapoyiannis BG, Mitchell R, Spector SA, Lie YS, Liu N, Bates MP, Weider JM. Prevalence of HIV DR among recently initiated adolescents. Jof Inf diseases. 2014;209(11):1505–9. Aldrovandi G, Viani RM, Peralta L, Kapoyiannis BG, Mitchell R, Spector SA, Lie YS, Liu N, Bates MP, Weider JM. Prevalence of HIV DR among recently initiated adolescents. Jof Inf diseases. 2014;209(11):1505–9.
22.
go back to reference Abadia-Barrero CE, Larusso MD. The disclosure model versus a developmental illness experience model for children and adolescents living with HIV/AIDS in Sao Paulo, Brazil. AIDS Patient Care STDs 2006; 20(1):36–43. [PubMed].CrossRef Abadia-Barrero CE, Larusso MD. The disclosure model versus a developmental illness experience model for children and adolescents living with HIV/AIDS in Sao Paulo, Brazil. AIDS Patient Care STDs 2006; 20(1):36–43. [PubMed].CrossRef
24.
go back to reference Cowan F, Pettifor A. HIV in adolescents in sub-Saharan Africa. Curr Opin HIV AIDS. 2009;4(4):288–93.CrossRef Cowan F, Pettifor A. HIV in adolescents in sub-Saharan Africa. Curr Opin HIV AIDS. 2009;4(4):288–93.CrossRef
25.
go back to reference Lall P, Lim SH, Khairuddin N, et al. Review: an urgent need for research on factors impacting adherence to and retention in care among HIV-positive youth and adolescents from key populations. J Int AIDS Soc. 2015;18(2 suppl 1):19393.PubMedPubMedCentral Lall P, Lim SH, Khairuddin N, et al. Review: an urgent need for research on factors impacting adherence to and retention in care among HIV-positive youth and adolescents from key populations. J Int AIDS Soc. 2015;18(2 suppl 1):19393.PubMedPubMedCentral
Metadata
Title
Virological failure among adolescents on ART, Harare City, 2017- a case-control study
Authors
Zvanaka Sithole
Elizabeth Mbizvo
Prosper Chonzi
More Mungati
Tsitsi Patience Juru
Gerald Shambira
Notion Tafara Gombe
Mufuta Tshimanga
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3372-6

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue